Company · Pharmaceuticals & Biotechnology
Biogen, Inc
Federal civil lawsuits naming Biogen, Inc, a Pharmaceuticals & Biotechnology company.
- Ticker
- Nasdaq: BIIB
- Business
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- Delaware
- SEC CIK
- 875045
Biogen, Inc is a public company in Biological Products, (No Diagnostic Substances), based in Cambridge, MA (traded on Nasdaq as BIIB, incorporated in Delaware). It appears in 45 federal civil lawsuits in this index, most often as a defendant (31 of 45). These cases are most often Patent and Civil Rights matters, filed between 1994 and 2026, most frequently in District Court, D. Massachusetts. The most common causes of action are Patent Infringement, Securities, and Antitrust. Frequent opposing parties include Berlex Laboratories, Gray, and Genentech, Inc.
45
Lawsuits
31
As Defendant
14
As Plaintiff
7
Open
38
Terminated
1994–2026
Span
12 mo
Median Duration
1.4 cases/yrPredominantly defendant · 69%Activity rising
Cases by State
Open Cases Over Time
1994peak 7 open2026
Case Types Over Time
19942026
PatentCivil RightsSecurities / CommoditiesContractAntitrust
Filings by Year
19942026